In the United States alone, more than 2.5 million patients with symptomatic coronary heart disease (CHD) are not amenable to percutaneous coronary intervention (angioplasty with stent deployment) or coronary artery bypass grafting (CABG) surgery because of unsuitable coronary anatomy, multiple previous revascularization attempts, age, additional...

Heart disease is the number one cause of death for both men and women in the United States. An estimated 83.6 million American adults have one or more types of Cardiovascular disorders. Of these, 42.2 million are estimated to be...

EECP® is a non-invasive treatment for patients who are suffering from chest pain, shortness of breath, weakness, fatigue, pain in the jaw or back or fullness in the chest; all are possible signs of angina. EECP® treatment can reduce or eliminate the frequency and intensity of...

When patients have angina, their bodies are telling them that their heart is not receiving enough oxygen. A treatment, in harmony with patients' heart, can improve circulation to the heart muscle. After EECP® treatment, patients may find that they: walk farther are more active have fewer attacks of...